AST 2015 - Cutting Edge of Transplantation
FR03 - Moderated Discussion
Feb 6, 2015 12:00pm ‐ Feb 6, 2015 1:00pm
What are the barriers to drug development for transplantation?
How can Industry, Academics, Clinicians and Government work together to define the problems and solutions to drug development?
Will the model for funding transplantation research change in the future?
How can we involve government, industry and academia to appropriately design a repositioning study that could lead to a transplant indication?
Rita R. Alloway
, PharmD, University of Cincinnati
Roslyn B. Mannon
, MD, FAST, FASN, University of Nebraska Medical Center
, MD, University of Alberta
E. Steve Woodle
, MD, Bristol-Myers Squibb
You must be logged in and own this session in order to post comments.
© 2021 Digitell, Inc. All Rights Reserved